Skip to content
Law and legal tech, in three minutesGet the 7 a.m. briefDaily Brief PodcastMenu

Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.

AnnouncementAnnounced by Gibson, Dunn & Crutcher · · summarized by LexCircuit Desk

Gibson Dunn says it advises North Immunology on Aethlon merger and financing

Gibson Dunn announced that it was advising North Immunology on a merger with Aethlon Medical and a concurrent private placement. The firm said the financing was expected to fund the combined company into the second half of 2028 and identified corporate, tax, benefits, securities and antitrust lawyers on its team.

Key points

Gibson Dunn

The announcement

Firm